Table 2.
Potential anti-RA mechanisms of some compounds.
| Compound | Mechanism | Model | References |
|---|---|---|---|
| stigmasterol | Suppressed proinflammatory mediators and increased anti-inflammatory cytokine through down-regulating NF-kB, p65 and p38MAPK | CIA | Ahmad et al. (2020)30 |
| β-Sitosterol | Inhibited synovial angiogenesis by suppressing endothelial cells proliferation and migration | CIA | Qian et al. (2022)31 |
| Repressed the M1 polarization and augmented M2 polarization | mø | Liu et al. (2019)48 | |
| Quercetin | Inhibited the release of proinflammatory cytokine (IL-6, TNF-α, IL-1β, IL-8, IL-13, IL-17) by activating SIRT1 | CIA | Shen et al. (2021)49 |
| Inhibited NLRP3 inflammasome activation and activated HO-1-mediated anti-inflammatory response via modulating the Th17/Treg balance | CIA | Yang et al. (2017)50 | |
| Inhibited IL-17 and RANKL production, suppressed Th17 cell | FLS | Kim et al. (2019)33 | |
| Modulated the immune response to arthritis via attenuation of the purinergic system (E-NTPDase and E-ADA activities) and the levels of IFN-γ and IL-4 | CFA | Saccol et al. (2019)51 | |
| Kaempferol | Inhibited RAFLS proliferation, migration, and inflammatory cytokines by suppressing FGFR3-RSK2 signaling | FLS | Lee et al. (2018)34 |
| Inhibited RAFLS migration and invasion by blocking MAPK pathway | FLS | Pan et al. (2017)52 | |
| Enhanced the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation | Treg | Lin et al. (2015)53 | |
| Inhibited RAFLS proliferation, reduced MMPs, COX-2, and PGE2 production, inhibited NF-κB activation | FLS | Yoon et al. (2013)54 |